Are you planning to attend BioProcess International US 2025 in Boston, MA between September 15-18?

If so, make sure to connect with Abzena at the event in booth #911. Our scientific experts, including our Head of Cell Line Development, Brett Verstak, Head of Business Development for Europe & APAC, Jonathan Cruickshank, and VP of Business Development, Julie Grace, will be on hand to discuss all your complex antibody engineering and development needs.

Make sure not to miss our presentation on Day 1 of the conference at 3:00pm, where Brett Verstak will be presenting, “Leveraging Analytics to Ensure Stable & Scalable Cell Lines”.   Gain valuable insights into our enhanced AbZelectPRO mammalian cell line development platform, which enables the rapid delivery of stable, high-producing cell lines for complex biologics or bioconjugates.

At Abzena, we work to give you the best chance of success by combining over 20 years of expertise with state-of-the-art analytics services to minimize risk downstream.

Discover Abzena’s next-generation platforms and solutions that empower you to deliver transformative therapies with quality, and scalability.

Event Details:

Dates: September 15-18
Location: Hynes Convention Center, Boston, MA, USA
Event website: BioProcess International US 2025

Complete the form below to schedule a meeting and learn how Abzena’s integrated solutions can help accelerate your biologic drug development journey.

About Abzena

Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. We have research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.